August 2014

1
Aug

Ichor Therapeutics, Inc. raises $383,000 for contract research from BioSenex, Ltd.

Syracuse, NY: Ichor Therapeutics, Inc., a pre-clinical biotechnology company that develops technologies to target age-related pathology, announced today that it has raised $383,000 for contract research from BioSenex, Ltd. BioSenex is a new venture that aims to develop supplement-based formulations to treat chronic disease. BioSenex will also enter as a contender for the Rejuvenation Mprize, a multi-million dollar competition to

Read more